PYR
Navalo Financial Services Group Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-26.34%
Annual Growth
4 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Payright Ltd. engages in the provision of payment plan services. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-12-23. The firm provides point of sale consumer finance solutions. The principal activity of the Company and its subsidiaries is to provide merchants with flexible lending finance solutions to offer their customers, intended for higher value transactions that are more considered purchases rather than smaller impulse-driven buys. The firm practices lending and performs identification and credit checks to ensure a customer’s repayment capability. Merchants are paid upfront and in full on the same day and include a diverse mix of broad-reaching products and services, such as direct sales businesses, home improvement, education, photography, dental, and health and beauty. The firm provides services to customers and merchants in Australia and New Zealand.
📈 Performance
Price History
-99.21%
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.01
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in PYR
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in PYR
856 days
PYR investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in PYR also invest in...
Bellevue Gold Ltd. engages in the exploration and evaluation of minerals and mine development in Australia. The company is headquartered in Perth, Western Australia. The company went IPO on 2005-12-20. The Company’s principal activities include the development of the Bellevue Gold Project, located approximately 40 kilometers (km) to the north-west of Leinster in the Goldfields region of Western Australia. The firm is developing a high-grade underground gold mine at the Bellevue Gold Project. Its projects include Bellevue Gold Project, South Yandal Project and Kathleen Valley Project. The South Yandal Project covering, about 867 square kilometers is an advanced exploration project located in a gold province. The project is located approximately 40 km to the east of the Bellevue Gold Project. The project covers significant, untested anomalous gold in soils. The Kathleen Valley Project is located immediately to the north of the Bellevue Gold Project and covers approximately 20 km along strike from the Bellevue Mine.
📊 Share price
$1.27 AUD
Buru Energy Ltd. engages in the exploration of oil and gas properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2008-09-01. The firm is engaged in production and exploration of oil and gas. The Company’s petroleum assets and tenements are located onshore in the Canning Basin in the southwest Kimberley region of Western Australia and the onshore Carnarvon Basin in Western Australia. In the Kimberley it owns and operates 50% of the conventional Ungani Oilfield project and the conventional gas condensate discovery. The company also operates a Canning Basin wide portfolio of exploration permits and licenses prospective for conventional and unconventional resources with working interests ranging from 60% to 100%. Its onshore Carnarvon Basin holdings are prospective for conventional oil and gas and have significant potential for carbon capture and storage activity. The firm is also involved in natural hydrogen, carbon capture and storage, and battery minerals activities.
📊 Share price
$0.10 AUD
Strike Energy Ltd. engages in the exploration and development of oil and gas resources. The company is headquartered in Perth, Western Australia. The company went IPO on 2004-08-05. The Group is engaged in the exploration and development of oil and gas resources in Australia. The Company’s projects include Perth Basin, Greater Erregulla Gas, West Erregulla, Project Haber, Perth Basin Geothermal, and Walyering. The Perth Basin project is located close to energy transmission infrastructure that is connected to Western Australia’s population center in the Southwest. Its Perth Basin gas and geothermal acreage is located in Western Australia’s Midwest region. Project Haber is the Company’s vertically integrated low-carbon urea fertilizer production facility, which produces over 1.4 metric tons per annum (mtpa) of granular urea. The firm owns 100% of the geothermal rights in the Perth Basin, covering approximately 3,500 square kilometers (km2).
📊 Share price
$0.47 AUD
Prospa Group Ltd. is a financial technology company that engages in the design, build, and utilize cloud-based, data rich and application program interface-enabled technologies. The company is headquartered in Sydney, New South Wales. The company went IPO on 2019-06-11. The firm is a provider of cash flow products and services. The Company’s operations consist primarily of the provision of loans to small businesses in Australia and New Zealand. The company facilitates referrals and customer acquisitions from a network of distribution partners, including finance brokers, aggregator networks, online affiliates, accountants and other advisers. The purpose-built credit decision engine (CDE) enables approvals and adoption of dynamic risk-based pricing, where interest rates associated with a facility are based on credit risk assessments for individual customers. Its CDE allows the business to quickly evaluate opportunities and potential risks across the portfolio. Its product suite includes a Small Business Loan and a Line of Credit. The firm has launched Prospa Plus Business Loans, offering higher credit quality for small to medium enterprises (SME).
📊 Share price
$0.33 AUD
Little Green Pharma Ltd. produces medicinal cannabis products for sale to Australian patients. The company is headquartered in Perth, Western Australia. The company went IPO on 2020-02-20. The firm has two global production sites for the manufacture of its own-branded and white-label ranges of Good Manufacturing Practice (GMP)-grade medicinal cannabis products, being a 21,500 square meters cultivation and 4,000 square meters GMP manufacturing facility capable of producing over 30 tons of medicinal cannabis biomass per annum located in Denmark (EU) and an indoor cultivation and manufacturing facility located in Western Australia capable of producing three tons of medicinal cannabis biomass per annum. The firm focuses on patient access in the global medicinal cannabis market and is actively engaged in promoting education and outreach programs, as well as participating in clinical investigations and research projects to develop new delivery systems.
📊 Share price
$0.17 AUD
Want more shares? Try these...
Qualitas Ltd. engages in real estate management services. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-12-16. The firm is focused on private credit and equity across commercial real estate sectors. The firm operates through two segments: Funds Management and Direct Lending. The Funds Management segment includes all of its core funds management activities and includes funds management fees, performance fees and other fee income. The company also includes dividends and distributions from its co-investment and direct lending activities. The Direct Lending segment relates to the interest income and expenses relating to activities undertaken by the Company's wholly owned subsidiaries, Arch Finance and Peer Estate. Arch Finance is a non-bank commercial real estate mortgage originator and lender. The company has access to diversified investment opportunities across commercial real estate markets, capital structures, fund types, and real estate sub-asset classes.
📊 Share price
$2.64 AUD
Qantas Airways Ltd. provides air transportation services. The company is headquartered in Mascot, New South Wales. The firm is focused on the operation of international and domestic air transportation services, the provision of freight services, and the operation of a frequent flyer loyalty program. The firm's segments include Qantas Domestic, Qantas International, Jetstar Group and Qantas Loyalty. The Qantas Domestic, Qantas International, and Jetstar Group are engaged in passenger flying business and air cargo and express freight businesses. The Qantas Loyalty segment is engaged in the customer loyalty recognition programs. Its main business is the transportation of customers using two airline brands, which include Qantas and Jetstar. Its airline brands operate in regional, domestic and international services. The firm operates in Australia, New Zealand, South Pacific, Asia, Europe, North and South America, and Africa.
📊 Share price
$6.51 AUD
NULL AIRLINES
PYC Therapeutics Ltd. is a drug-development company, which offers a new generation of RNA therapeutics to meet unmet need in disease. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2005-03-30. The firm has RNA targeted therapeutics design capabilities to deliver technologies based on cell penetrating peptides (CPPs) and peptide conjugated phosphorodiamidate morpholino oligomer (PPMOs). The firm develops a pipeline of therapies, including two programs, which are focused on inherited eye diseases and preclinical discovery programs, which are focused on neurodegenerative and kidney diseases. The Company’s lead drug candidate, VP-001 is designed to treat Retinitis pigmentosa 11 (RP11). The second lead drug candidate PYC-001, which is focused on treating autosomal dominant optic atrophy (ADOA). Its preclinical, clinical, regulatory and corporate operations are based in San Diego, California. The firm's discovery and laboratory operations are located in Australia.
📊 Share price